NLSP NLS Pharmaceutics
- 0.1399
- +0.0039+2.87%
- 0.1405
- +0.0006+0.43%
NLS Pharmaceutics News
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 20-F: FY2022 Annual Report
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 20-F: FY2021 Annual Report
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
Analysis
Price Target
No Data
